244 related articles for article (PubMed ID: 10639567)
41. Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cells.
Renner U; Lohrer P; Schaaf L; Feirer M; Schmitt K; Onofri C; Arzt E; Stalla GK
Endocrinology; 2002 Oct; 143(10):3759-65. PubMed ID: 12239085
[TBL] [Abstract][Full Text] [Related]
42. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma.
Kawakami T; Tokunaga T; Hatanaka H; Kijima H; Yamazaki H; Abe Y; Osamura Y; Inoue H; Ueyama Y; Nakamura M
Cancer; 2002 Nov; 95(10):2196-201. PubMed ID: 12412174
[TBL] [Abstract][Full Text] [Related]
43. Differential expression of VEGF isoforms in mouse during development and in the adult.
Ng YS; Rohan R; Sunday ME; Demello DE; D'Amore PA
Dev Dyn; 2001 Feb; 220(2):112-21. PubMed ID: 11169844
[TBL] [Abstract][Full Text] [Related]
44. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
[TBL] [Abstract][Full Text] [Related]
45. Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165.
Gu C; Limberg BJ; Whitaker GB; Perman B; Leahy DJ; Rosenbaum JS; Ginty DD; Kolodkin AL
J Biol Chem; 2002 May; 277(20):18069-76. PubMed ID: 11886873
[TBL] [Abstract][Full Text] [Related]
46. Immunolocalization of vascular endothelial growth factor in the GH3 cell line.
Vidal S; Oliveira MC; Kovacs K; Scheithauer BW; Lloyd R
Cell Tissue Res; 2000 Apr; 300(1):83-8. PubMed ID: 10805077
[TBL] [Abstract][Full Text] [Related]
47. Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis.
Ikeda M; Hosoda Y; Hirose S; Okada Y; Ikeda E
J Pathol; 2000 Aug; 191(4):426-33. PubMed ID: 10918218
[TBL] [Abstract][Full Text] [Related]
48. Vascular endothelial growth factor expression and angiogenesis induced by chronic cerebral hypoperfusion in rat brain.
Hai J; Li ST; Lin Q; Pan QG; Gao F; Ding MX
Neurosurgery; 2003 Oct; 53(4):963-70; discussion 970-2. PubMed ID: 14519228
[TBL] [Abstract][Full Text] [Related]
49. Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish.
Lee P; Goishi K; Davidson AJ; Mannix R; Zon L; Klagsbrun M
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10470-5. PubMed ID: 12142468
[TBL] [Abstract][Full Text] [Related]
50. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
51. Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells.
Gloddek J; Pagotto U; Paez Pereda M; Arzt E; Stalla GK; Renner U
J Endocrinol; 1999 Mar; 160(3):483-90. PubMed ID: 10076194
[TBL] [Abstract][Full Text] [Related]
52. Transcriptional regulation of vascular endothelial growth factor expression in epithelial and stromal cells during mouse mammary gland development.
Hovey RC; Goldhar AS; Baffi J; Vonderhaar BK
Mol Endocrinol; 2001 May; 15(5):819-31. PubMed ID: 11328861
[TBL] [Abstract][Full Text] [Related]
53. The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas.
Hunter JA; Skelly RH; Aylwin SJ; Geddes JF; Evanson J; Besser GM; Monson JP; Burrin JM
Eur J Endocrinol; 2003 Feb; 148(2):203-11. PubMed ID: 12590639
[TBL] [Abstract][Full Text] [Related]
54. Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor.
Ma J; Fei ZL; Klein-Szanto A; Gallo JM
Clin Exp Metastasis; 1998 Aug; 16(6):559-68. PubMed ID: 9872603
[TBL] [Abstract][Full Text] [Related]
55. Expression of vascular endothelial growth factor receptors in smooth muscle cells.
Ishida A; Murray J; Saito Y; Kanthou C; Benzakour O; Shibuya M; Wijelath ES
J Cell Physiol; 2001 Sep; 188(3):359-68. PubMed ID: 11473363
[TBL] [Abstract][Full Text] [Related]
56. The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases.
Poltorak Z; Cohen T; Neufeld G
Herz; 2000 Mar; 25(2):126-9. PubMed ID: 10829252
[TBL] [Abstract][Full Text] [Related]
57. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
[TBL] [Abstract][Full Text] [Related]
58. Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells.
Zhang L; Conejo-Garcia JR; Yang N; Huang W; Mohamed-Hadley A; Yao W; Benencia F; Coukos G
Biochem Biophys Res Commun; 2002 Apr; 292(4):860-8. PubMed ID: 11944893
[TBL] [Abstract][Full Text] [Related]
59. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
60. Expression of vascular endothelial growth factor in otitis media.
Jung HH; Kim MW; Lee JH; Kim YT; Kim NH; Chang BA; Choi JO; Lim HH
Acta Otolaryngol; 1999; 119(7):801-8. PubMed ID: 10687938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
